We could note that we did not select miR-135b because of absence of expression in our screening series whereas this microRNA would be differentially expressed in ER+ and ER− breast tumors, and is described by Aakula et al. as a regulator of ER [37]. Here, ESR1 is linked to breast neoplasm.